Jaglal, SB, Guilcher, SJ, Bereket, T, et al. Development of a Chronic Care Model for Neurological Conditions (CCM-NC). BMC Health Servi Res. 2014;14:409.
Barry, MJ, Edgman-Levitan, S. Shared decision making—the pinnacle of patient-centered care. N Engl J Med. 2012;366:780-781.
van der Eijk, M, Nijhuis, FA, Faber, MJ, Bloem, BR. Moving from physician-centered care towards patient-centered care for Parkinson’s disease patients. Parkinson Relat Disorders. 2013;19:923-927.
Berwick, DM. What ‘patient-centered’should mean: confessions of an extremist. Health Affairs. 2009;28:w555-w565.
Wilson, E, Seymour, J, Aubeeluck, A. Perspectives of staff providing care at the end of life for people with progressive long-term neurological conditions. Palliat Support Care. 2011;9:377-385.
Nance, MA. Comprehensive care in Huntington’s disease: a physician’s perspective. Brain Res Bull. 2007;72:175-178.
Roos, RA. Huntington’s disease: a clinical review. Orphanet J Rare Dis. 2010;5:40.
Sturrock, A, Leavitt, BR. The clinical and genetic features of Huntington disease. J Geriatr Psychiatry Neurol. 2010:0891988710383573.
Turner, C, Hilton-Jones, D. The myotonic dystrophies: diagnosis and management. J Neurol Neurosurg Psychiatry. 2010;81:358-367.
Gagnon, C, Noreau, L, Moxley, RT, et al. Towards an integrative approach to the management of myotonic dystrophy type 1. J Neurol Neurosurg Psychiatry. 2007;78:800-806.
Harper, PS. Myotonic dystrophy, 3rd ed. London: Harcourt Publishers, Ltd.; 2001.
Winblad, S, Lindberg, C, Hansen, S. Temperament and character in patients with classical myotonic dystrophy type 1 (DM-1). Neuromusc Disord. 2005;15:287-292.
Meola, G, Sansone, V. Cerebral involvement in myotonic dystrophies. Muscle Nerve. 2007;36:294-306.
Chouinard, MC, Gagnon, C, Laberge, L, et al. The potential of disease management for neuromuscular hereditary disorders. Rehabil Nurs. 2009;34:118-126.
Bonelli, RM, Hofmann, P. A review of the treatment options for Huntington’s disease. Exp Opin Pharmacother. 2004;5:767-776.
de Die-Smulders, C, Höweler, C, Thijs, C, et al. Age and causes of death in adult-onset myotonic dystrophy. Brain. 1998:1211557-1211563.
Mathieu, J, Allard, P, Potvin, L, Prevost, C, Begin, P. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology. 1999;52:1658.
Sørensen, S, Fenger, K. Causes of death in patients with Huntington’s disease and in unaffected first degree relatives. J Med Genet. 1992;29:911-914.
Di Maio, L, Squitieri, F, Napolitano, G, Campanella, G, Trofatter, JA, Conneally, PM. Suicide risk in Huntington’s disease. J Medi Genet. 1993;30:293-295.
Nance, MA. Therapy in Huntington’s disease: where are we?
Curr Neurol Neurosci Rep. 2012;12:359-366.
Charmaz, K. Constructing grounded theory: a practical guide through qualitative analysis. London: SAGE; 2006.
Charmaz, K. Constructing grounded theory, 2nd ed. Los Angeles, CA: SAGE; 2014.
Williams, JK, Hamilton, R, Nehl, C, et al. “No one else sees the difference:” family members’ perceptions of changes in persons with preclinical Huntington disease. Am J Med Genet B. 2007;144:636-641.
Williams, JK, Skirton, H, Barnette, JJ, Paulsen, JS. Family carer personal concerns in Huntington disease. J AdvNurs. 2012;68:137-146.
Timman, R, Tibben, A, Wintzen, AR. Myotonic dystrophy: the burden for patients and their partners. J Rehabil Medi. 2010;42:823-830.
Cup, EH, Kinébanian, A, Satink, T, et al. Living with myotonic dystrophy; what can be learned from couples? A qualitative study. BMC Neurol. 2011;11:86.
Boström, K, Ahlström, G. Living with a hereditary disease: persons with muscular dystrophy and their next of kin. Am J Med Genet A. 2005;136:17-24.
Roscoe, LA, Corsentino, E, Watkins, S, McCall, M, Sanchez-Ramos, J. Well-being of family caregivers of persons with late-stage Huntington’s disease: lessons in stress and coping. Health Commun. 2009;24:239-248.
Quarrell, OW, Brewer, HM, Squitieri, F. Juvenile Huntington’s disease: and other trinucleotide repeat disorders. Oxford University Press; 2009.
Hinton, L, Franz, CE, Reddy, G, Flores, Y, Kravitz, RL, Barker, JC. Practice constraints, behavioral problems, and dementia care: primary care physicians’ perspectives. J Gen Intern Medi. 2007;22:1487-1492.
Heatwole, C, Bode, R, Johnson, N, et al. Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1). Neurology. 2012;79:348-357.
LaDonna, KA, Koopman, WJ, Ray, SL, Venance, SL. Hard to swallow: a phenomenological exploration of caring for individuals with myotonic dystrophy (DM1) and dysphagia. J Neurosci Nurs. 2016;48:42-51.
Gagnon, C, Mathieu, J, Noreau, L. Life habits in myotonic dystrophy type 1. J Rehabil Med. 2007;39:560-566.
Strömberg, A, Mårtensson, J, Fridlund, B, Levin, L-Å, Karlsson, J-E, Dahlström, U. Nurse-led heart failure clinics improve survival and self-care behaviour in patients with heart failure. Eur Heart J. 2003;24(11):1014-1023.
Moore, S, Corner, J, Haviland, J, et al. Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial. BMJ. 2002;325:1145.
Denver, EA, Barnard, M, Woolfson, RG, Earle, KA. Management of uncontrolled hypertension in a nurse-led clinic compared with conventional care for patients with type 2 diabetes. Diabetes Care. 2003;26:2256-2260.
Gagnon, C, Mathieu, J, Jean, S, Laberge, L, Perron, M, Veillette, S, et al. Predictors of disrupted social participation in myotonic dystrophy type 1. Arch Phys Med Rehabil. 2008;89:1246-1255.